A major move is in the offing as Viking Therapeutics Inc. (VKTX) market cap hits 664.08 million

Viking Therapeutics Inc. (NASDAQ: VKTX) kicked off on January 24, 2023, at the price of $8.44, up 2.13% from the previous trading day. During the day, the shares moved up to $8.64 and dropped to $8.3312 before settling in for the closing price of $8.44. Over the past 52 weeks, VKTX has traded in a range of $2.02-$9.62.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


While this was happening, its average annual earnings per share was recorded -30.90%. With a float of $67.77 million, this company’s outstanding shares have now reached $76.50 million.

Considering the fact that the conglomerate employs 17 people, you should pay attention to its efficiency factor.

Viking Therapeutics Inc. (VKTX) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc. is 11.78%, while institutional ownership is 35.70%. The most recent insider transaction that took place on May 02, was worth 111,195. In this transaction Director of this company bought 45,000 shares at a rate of $2.47, taking the stock ownership to the 111,250 shares.

Viking Therapeutics Inc. (VKTX) Earnings and Forecasts

In the latest quarterly report, which was put into the public domain on 9/29/2022, the organization reported -$0.21 earnings per share (EPS), higher than consensus estimate (set at -$0.23) by $0.02. This company achieved a return on equity of -24.65. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -30.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to 4.70% growth over the previous five years of trading.

Viking Therapeutics Inc. (NASDAQ: VKTX) Trading Performance Indicators

Take a look at Viking Therapeutics Inc.’s (VKTX) current performance indicators. Last quarter, stock had a quick ratio of 11.70.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.98 in one year’s time.

Technical Analysis of Viking Therapeutics Inc. (VKTX)

Compared to the last year’s volume of 1.87 million, its volume of 1.51 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 20.00%. Additionally, its Average True Range was 0.58.

During the past 100 days, Viking Therapeutics Inc.’s (VKTX) raw stochastic average was set at 85.89%, which indicates a significant increase from 38.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.33% in the past 14 days, which was lower than the 114.05% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.16, while its 200-day Moving Average is $3.81. Nevertheless, the first resistance level for the watch stands at $8.73 in the near term. At $8.84, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.04. If the price goes on to break the first support level at $8.42, it is likely to go to the next support level at $8.22. Should the price break the second support level, the third support level stands at $8.11.

Viking Therapeutics Inc. (NASDAQ: VKTX) Key Stats

The company with the Market Capitalisation of 664.08 million has total of 76,688K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -54,990 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -15,773 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

5 Best TaaS Stocks to Buy Right Now

TaaS stock refers to a financial asset sold by...

Fortinet Inc. (FTNT) recently have taken one step ahead with the beta value of 1.14

As on January 25, 2023, Fortinet Inc. (NASDAQ: FTNT) got off with the flyer as it spiked 1.31% to $51.76. During the day, the...

A Little Luck Can Go a Long Way with Rackspace Technology Inc. (RXT) as it 5-day change was 0.35%

Rackspace Technology Inc. (NASDAQ: RXT) started the day on January 25, 2023, with a price decrease of -1.71% at $2.87. During the day, the...

Vascular Biogenics Ltd. (VBLT) 14-day ATR is 0.01: This Stock is Set to Soar Above its Peers

Vascular Biogenics Ltd. (NASDAQ: VBLT) open the trading on January 25, 2023, with great promise as it jumped 1.27% to $0.16. During the day,...


Please enter your comment!
Please enter your name here